Oracle Health Sciences Adds 93 Emerging Biopharma Customers
Oracle Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year. These include sponsors Accera and NewLink Genetics and CROs FMD K&L and 4C Pharma Solutions.
- FMD K&L adopted Oracle Health Sciences InForm to help ensure data accuracy and efficiencies.
- Accera, a biotechnology company focused on conditions affecting the central nervous system, uses cloud-based Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service to model scenarios for future trials.
- 4C Pharma Solutions and NewLink Genetics use Oracle Argus Safety for insight into product-safety issues, improved productivity, and streamlined safety reporting.
Read the full release.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
